Labroots to Host Diagnostica Stago, Inc.'s Latest Webinar in the Ongoing Stago EdVantage Virtual University, September 7, 2022
The newest webinar brought to the Stago Edvantage Virtual University will explore the unique challenges when transitioning a patient from a direct oral anticoagulant to a heparin infusion for patients at high risk of thrombosis
PARSIPPANY, N.J., Aug. 25, 2022 /PRNewswire-PRWeb/ -- August 25, 2022 (Parsippany, NJ) Diagnostica Stago, Inc., currently the only independent international group in the In Vitro Diagnostics industry dedicated to hemostasis and thrombosis exploration, has invited Michael P. Gulseth, Pharm.D., BCPS, FMSHP, FASHP, Anticoagulation Stewardship Director at Sanford USD Medical Center in Sioux Falls, SD, and Clinical Associate Professor, Department of Internal Medicine, at the University of South Dakota Sanford School of Medicine, to present his work in the latest webinar for the ongoing Stago EdVantage Virtual University, September 7th, 2022. The webinar titled, "Managing Direct Oral Anticoagulant Inhibitor to Heparin Conversion; Heparin Anti-Xa assay or aPTT?", will cover a recently published comprehensive practice guideline on how to manage patient transitions from a direct oral anticoagulant to a heparin infusion, along with an assessment of its performance versus an alternative strategy.
Ever since the introduction of direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, laboratory staff and clinicians have faced many challenges in determining ideal practices and guidelines when transitions to heparin infusions are needed for patients at high risk of thrombosis. Although heparin infusions are commonly needed for patients on DOACs who are admitted to the acute care setting, little guidance has been provided on how to manage such transitions. To overcome these challenges, clinicians and their laboratory partners have been developing optimal processes to manage transitions to heparin infusions. During Dr. Gulseth's presentation, he will compare heparin anti-Xa assay levels to aPTT to manage heparin infusions and evaluate recent literature developments on how to manage DOAC to heparin transitions. Additionally, he will discuss how to appropriately interpret laboratory values when presented with a patient on a DOAC transitioning to heparin to appropriately manage the transition.
Running since 2016, the Stago EdVantage Virtual University is an educational platform that demystifies coagulation testing with on-demand webinars and a virtual exhibit hall exploring basic and complex concepts, making them accessible to novices as well as experienced users. With more than 20 on-demand webinars, Stago EdVantage Virtual University is the longest-running virtual event hosted on the Labroots platform.
For more information about Dr. Gulseth's webinar, "Managing Direct Oral Anticoagulant Inhibitor to Heparin Conversion; Heparin Anti-Xa assay or aPTT?", Stago EdVantage Virtual University, and to register free of cost, click here.
About Diagnostica Stago, Inc.
Diagnostica Stago, Inc. is the exclusive provider of the Diagnostica Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Stago works with you to design a comprehensive hemostasis solution to fit the unique needs of your laboratory. Their unique approach focuses on improving patient outcomes and reducing the overall cost of care. Rest assured with reliable results from their standardized testing platforms. Expert support services combined with a complete menu of routine and specialty assays enable you to focus on your patients while they focus on you.
About Labroots
Labroots is the leading scientific social networking website and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.
Media Contact
Lynn Brainard, Labroots, Inc., 714-771-4397, [email protected]
SOURCE Labroots, Inc.
Share this article